The rising impact of biomarkers in early clinical development
Drug Target Review
APRIL 7, 2025
Conclusion As science advances, medical and regulatory frameworks continue to adjust and evolve to accommodate new tools and methods. As biomarkers become increasingly relevant in indicating the workings and effects of novel therapies, their potential as valuable clinical and regulatory endpoints is also gaining recognition.
Let's personalize your content